Following Companies

 
Stock Quotes for Following Companies top ^
  • Industry: Banks - Regional - Europe
  • Sector: Financial Services
  • Stock Style: Large Core
  • Morningstar Rating: 3 Stars
Sign-up for xetr%3acbk investment picks
  • Industry: Banks - Regional - Europe
  • Sector: Financial Services
  • Stock Style: Large Core
  • Stock Type: Cyclical
  • Morningstar Rating: 3 Stars
Sign-up for cbk investment picks
  • Industry: Banks - Regional - Europe
  • Sector: Financial Services
  • Stock Style: Large Core
  • Stock Type: Cyclical
Sign-up for cbk investment picks
  • Industry: Banks - Regional - Europe
  • Sector: Financial Services
  • Stock Style: Large Core
Sign-up for czb investment picks
  • Industry: Banks - Regional - Europe
  • Sector: Financial Services
  • Stock Style: Large Core
Sign-up for com investment picks

 
News Articles for Following Companies top ^
Barclays Bank PLC (“Barclays”) and OFI Global Asset Management, which consists of OppenheimerFunds, Inc. and certain of its advisory subsidiaries, announced today that following the close of business on Friday, January 9, 2015, the following Index Constituents will be removed from the Barclays OFI SteelPath Midstream MLP Index (the “Index”): In addition to the above removals and also occurring following the close of business on Friday, January 9, 2015, the following constituents will be added to the Index: Western Gas Equity Partners LP (NYSE: WGP) DCP Midstream Partners LP (NYSE: DPM) Buckeye Partners LP (NYSE: BPL) QEP Midstream Partners LP (NYSE: QEPM)
Sign-up for Barclays and OFI Global Asset Management Announce the Following Changes to the Barclays OFI SteelPath Midstream MLP Index investment picks
A.M. Best has commented that the financial strength rating (FSR) of A (Excellent) and the issuer credit rating (ICR) of “a” of American Reliable Insurance Company (American Reliable) (Scottsdale, AZ) are unchanged following the announcement that Global Indemnity Group, Inc. (Global Indemnity), a subsidiary of Global Indemnity plc (Ireland) [NASDAQ:GBLI], has agreed to acquire American Reliable, a subsidiary of Assurant, Inc. (Assurant) (headquartered in New York) [NYSE:AIZ]. However, as discussed in detail below, the rating outlook for the ICR, which is currently positive for American Reliable, will likely be revised to stable following the completion of A.M. Best’s evaluation of the transaction after its close.
Sign-up for A.M. Best Comments on the Ratings of American Reliable Insurance Company Following Acquisition Announcement investment picks
http://media.marketwire.com/attachments/201211/54178_rand.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155850&ProfileId=051205&sourceType=1 BUFFALO, NY --
Sign-up for Rand Capital Increases Net Asset Value to $4.47, One New Investment in Crashmob, Inc., Two Follow-On Investments, Sale of QuaDPharma and Continued Stock Repurchase Plan investment picks
The Rubicon Project, Inc. (NYSE: RUBI), a leader in advertising automation and real-time trading platforms for the buying and selling of advertising, will present at the following investor conferences in November 2014: The RBC Capital Markets’ Technology, Internet, Media and Telecommunications Conference, to be held at the Westin Times Square, in New York on Tuesday, November 11 at 3:30PM ET.
Sign-up for Rubicon Project to Present at the Following Upcoming Investor Conferences investment picks
2014/10/30
Combined Entity to be Named Zimmer Biomet WARSAW, Ind.
Sign-up for Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing investment picks
2014/10/28
By Wallace Witkowski and Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- Facebook Inc. and Gilead Sciences Inc. shares are in focus in the extended session Tuesday, after the companies reported quarterly results following the close.
Sign-up for UPDATE: Facebook, Gilead shares slip after hours following earnings investment picks
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced safety and efficacy follow-up data on Iclusig ® (ponatinib), its approved BCR-ABL inhibitor, in patients with a baseline T315I mutation from its Phase 1 and Phase 2 PACE trials in heavily pretreated patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). With a median follow-up of three years for CP-CML patients and nine months overall, Iclusig continues to exhibit responses in patients with the T315I mutation, for whom there is no other approved tyrosine kinase inhibitor (TKI) therapy.
Sign-up for ARIAD Announces Follow-up Data from Phase 1 and PACE Trials of Ponatinib in Patients with T315I Mutation in Chronic Myeloid Leukemia investment picks
Gilead Sciences, Inc. (NASDAQ: GILD) today announced long-term follow-up results from the registration studies further describing the duration of response, progression-free survival (PFS) and safety profile for Zydelig ® (idelalisib) in relapsed patients with chronic lymphocytic leukemia (CLL) and two types of indolent non-Hodgkin lymphoma (iNHL). The findings are being presented this week at the Annual Meeting of the American Society of Hematology (ASH). Zydelig is indicated in the United States as monotherapy for patients with relapsed follicular B-cell non-Hodgkin lymphoma (FL) and small lymphocytic lymphoma (SLL) who have received at least two prior systemic therapies, and in combination with rituximab for patients with relapsed CLL for whom rituximab alone would be considered appropriate therapy due to comorbidities.
Sign-up for Gilead Presents Follow-up Data from Zydelig Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma investment picks
The Obama administration has slapped new sanctions on the government of North Korea following the recent cyberattack on Sony Pictures Entertainment (SNE) . The Treasury Department sanctioned the government-controlled Korea Mining Development Trading Corp.
Sign-up for UPDATE: U.S. slaps new sanctions on North Korea following Sony hack investment picks
The Obama administration has slapped new sanctions on the government of North Korea following the recent cyberattack on Sony Pictures Entertainment (SNE) . The Treasury Department sanctioned the government-controlled Korea Mining Development Trading Corp.
Sign-up for U.S. slaps new sanctions on North Korea following Sony hack investment picks
Genesis Energy, L.P. (NYSE: GEL) will hold a follow-up conference call at 10:30 a.m. Central time regarding its third quarter earnings.
Sign-up for Genesis Energy, L.P. Third Quarter Results Follow-Up Conference Call investment picks
A.M. Best has commented that the financial strength rating of A (Excellent) and the issuer credit ratings of “a” of Global Indemnity Reinsurance Company, Ltd.
Sign-up for A.M. Best Comments on Ratings of Global Indemnity Reinsurance Company, Ltd. Following Acquisition Deal With Assurant, Inc. investment picks
NEW YORK, Oct.
Sign-up for Borderfree to Present at the Following Upcoming Investor Conferences investment picks
2014/10/27
--Top-line Results Confirming Safety, Liver Transfection Presented at ESGCT Conference--
Sign-up for AIPGENE Consortium Presents 1 Year Follow-Up Clinical Data from Acute Intermittent Porphyria Phase I Clinical Trial Using AAV5-PBGD Gene Therapy Candidate investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Following Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Focused Strategy  |  Next: Food Bank